News | August 13, 2023
Krsnaa Diagnostics posts Q1 FY24 consolidated PAT at Rs. 14.64 Cr
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Continues to Expand its Presence in South India
5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
The blood test market worldwide is today around $75-80 billion
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Subscribe To Our Newsletter & Stay Updated
